GlaxoSmithKline has signed a drug development deal worth as much as $820 million with California company Valeant Pharmaceuticals International, the companies said Thursday. (VRX) (GSK)

Lees meer..

A drug Curis Inc. helped develop as a potential cancer treatment through contribution of some intellectual property will begin a midstage human clinical trial. (DNA)

Lees meer..

Valeant Pharmaceuticals International has entered a collaboration agreement with GlaxoSmithKline for the investigational drug retigabine, a neuronal potassium channel opener for treatment of adult epilepsy patients, the companies said Thursday. (VRX)

Lees meer..

AmeriStart has signed a sales, marketing and business-development contract with Factory CRO, a Dutch clinical research organization that conducts medical-device studies for regulatory approval.

Lees meer..

Nacre, the crown jewel of natural materials, has been extensively studied because of its remarkable physical properties for over 160 years. Yet, the precise structural features governing its extraordinary strength and its growth mechanism remain elusive.
Lees meer..

The National Science Foundation has awarded $356,000 to Cindy Lee, environmental chemist and a professor of environmental engineering and earth sciences at Clemson University, to look at how pollutants cycle through fish and other organisms and wind up on the dinner table. The research will focus on PCBs (polychlorinated biphenyls), pollutants that have been implicated in problems with brain development in humans.
Lees meer..

Drug maker Schering-Plough Corp. won approval from European regulators Wednesday to sell several animal medicines to Pfizer Corp., according to published reports. (PFE)

Lees meer..

Replidyne Inc. said Wednesday it’s cut 80 percent of its remaining workforce, leaving the biotech company with just five employees. (RDYN)

Lees meer..

The U.S. Food and Drug Administration has granted American Bio Medica Corp. a waiver it was seeking for its Rapid TOX drug test product line.

Lees meer..

Stereotaxis Inc. said Wednesday that it received regulatory clearance from the U.S. Food and Drug Administration for a radio-frequency guidewire designed to help patients with arterial disease.

Lees meer..